Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
By linking privacy-protected pharmacy records, HealthVerity Marketplace includes prescription data on more than 19.1 million patients taking GLP-1 drugs such as Ozempic, semaglutide, and Rybelsus
Semaglutide (Wegovy) is FDA-approved for chronic weight management (with criteria) and has strong clinical trial evidence for meaningful average weight loss when paired with lifestyle support
19 Cardiovascular Outcome Trials of SGLTis in Patients with Type 2 Diabetes SGLTis have emerged as potent agents for the reduction in MACE risk, hospitalizations for HF (HFH), and the progression of chronic kidney disease
(2021) showed that the GLP-1 RA drug class may be associated with a relative risk reduction for clinical kidney outcomes of 21% (HR 0.79
Published 2021 Nov 18
You dont have to navigate cravings, blood sugar swings, or stubborn weight loss alone
US$ 24.36
US$ 20.19
US$ 21.30
US$ 20.24
US$ 25.60
US$ 21.83
